NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
NEXGEL Announces Dial-In Details for Investor Update Call
NEXGEL announced dial-in details for its investor update call scheduled for September 24, 2026, at 4:15 p.m. Eastern Time.
The call will cover operational progress, commercialization initiatives, and other corporate matters, with a replay available through October 1, 2026.
This is a scheduling logistics release with no new financial or business content; any substance will come during the call itself.